Healthcare
Avon Technologies Plc(AVNBF)
Live Price
Offline$22.49
+0.00% today
1Y Change
-7.08%
Window
Jun 26, 2025 โ Jun 24, 2026
- Market Cap
- $520.00M
- Revenue Growth
- -12.6%
- EPS Growth
- +170.0%
- Dividend Yield
- 1.0%
Coverage: 250 bars ยท Jun 26, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Avon Technologies Plc (AVNBF) is a Healthcare stock with a market cap of $520.00M and listed on OTC. The stock last traded around $22.49 and down 7.1% across the available one-year price window (Jun 26, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of -12.6%, EPS growth of +170.0%, a dividend yield of 1.0%. What stands out right now is revenue -12.6%, EPS +170.0%, free cash flow -63.4% with operating margin 6.1% and ROIC 4.3%. The dividend is present but secondary, with a yield around 1.0%. Valuation already assumes a fairly strong business story at P/E 66.0 and price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines AVNBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-12.6% vs +7.6% peer median
Operating Margin
Below sector median
+6.1% vs +19.4% peer median
P/E
Above sector median
66.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
Q2 2026 was reported on May 15, 2026 with an EPS surprise of -15.1%.
The operating picture looks softer than before
Revenue is at -12.6% and EPS is at +170.0%, with operating margin around 6.1%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 2 reported quarters, the stock averaged +2.8% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 May 15, 2026 | -15.1% | +0.0% | +5.7% | +5.7% |
Q1 2026 Jan 23, 2026 | +16.1% | +0.0% | +0.0% | -10.5% |
Benchmark Edge
AVNBF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AVNBF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AVNBF Max Drawdown
-24.27%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for AVNBF and SPY.
Company Overview
Avon Technologies Plc
Other OTC
Avon Technologies Plc engages in the manufacture and design of respiratory protection products for defense and industrial users. The firm also offers polymer based products for the dairy and defense industries. It operates through the Respiratory Protection and Head Protection segments. The company was founded in 1885 and is headquartered in Melksham, the United Kingdom.
- Leadership
- Mark Josceline Sclater
- IPO Date
- Aug 15, 2012
- Employees
- 917
- Street Address
- Hampton Park West
- Mailing
- Melksham, SN12 6NB
- Region
- Melksham, GB
- Reporting Currency
- USD
- Investor Line
- 44 12 2589 6800
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 66.0
- EV/EBITDA
- 22.3
- Price/Sales
- 2.2
- Price/Book
- 3.1
Growth
- Revenue
- -12.6%
- EPS
- +170.0%
- Free Cash Flow
- -63.4%
Profitability
- Gross Margin
- 41.0%
- Operating Margin
- 6.1%
- Net Margin
- 3.3%
- ROE
- 4.6%
- ROIC
- 4.3%
Balance Sheet
- Debt/Equity
- 0.49
- Current Ratio
- 2.39
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.